Cargando…
Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities
BACKGROUND: Glioblastoma is the deadliest and most prevalent brain tumor. Dexamethasone (DXM) is a commonly used steroid for treating glioblastoma patients for alleviation of vasogenic edema and pain prior to treatment with chemotherapeutic drugs. Temozolomide (TMZ), an alkylating agent, has recentl...
Autores principales: | Das, Arabinda, Banik, Naren L, Patel, Sunil J, Ray, Swapan K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544397/ https://www.ncbi.nlm.nih.gov/pubmed/15588281 http://dx.doi.org/10.1186/1476-4598-3-36 |
Ejemplares similares
-
Ceramide Is Involved in Temozolomide Resistance in Human Glioblastoma U87MG Overexpressing EGFR
por: Bassi, Rosaria, et al.
Publicado: (2023) -
Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth
por: George, Joseph, et al.
Publicado: (2009) -
Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line
por: Markiewicz-Żukowska, Renata, et al.
Publicado: (2013) -
In Vitro Radiosensitizing Effects of Temozolomide on U87MG Cell Lines of Human Glioblastoma Multiforme
por: Borhani, Samira, et al.
Publicado: (2017) -
Temozolomide and tranilast synergistic antiproliferative effect on human glioblastoma multiforme cell line (U87MG)
por: Khazaei, Mozafar, et al.
Publicado: (2019)